司美格鲁肽与胰岛素抵抗研究现状的文献计量学分析
Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v7i1.11807
Abstract
目的：探究司美格鲁肽与胰岛素抵抗之间的相关性。方法：从Web of Science核心数据库下载近五年发表司美格鲁肽与胰岛素抵抗的文献,使用Citespace和bibliometrix从国家、机构、作者和关键词进行分析。结果：该领域发文量逐年增加；中国、美国发文量较多；多伦多大学为发文量最多的机构。研究关键词为胰岛素抵抗相关机制、肥胖。结论：对于司美格鲁肽与胰岛素抵抗相关研究在逐年增加,研究重点为司美格鲁肽与胰岛素抵抗作用机制和肥胖。
Keywords
文献计量学；司美格鲁肽；胰岛素抵抗
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] SALTIEL A R.Insulin signaling in health and disease [J/OL].The Journal of Clinical Investigation,2021,131(1):e142241, 142241.
[2] LOCATELLI J C, COSTA J G, HAYNES A, 等. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optim ize Changes in Body Composition?[J/OL].Diabetes Care,2024, 47(10):1718-1730.
[3] TAKANO C, OGAWA E, HAYAKAWA S. Insulin Resistance in Mitochondrial Diabetes[J/OL]. Biomolecules,2023,13(1):126.
[4] ZHAO Y, YUE R. Aging adipose tissue, insulin resistance, and type 2 diabetes[J/OL]. Biogerontology,2024,25(1):53-69.
[5] MAHAPATRA M K, KARUPPASAMY M, SAHOO B M. Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity,Non-Alcoholic Steatohepatitis and Neurodege nerative diseases: A Narrative Review[J/OL]. Pharmaceutical Research,2022,39(6):1233-1248.
[6] ABDUL-GHANI M,MAFFEI P,DEFRONZO R A.Managing insul in resistance: the forgotten pathophysiological component of type 2 diabetes[J/OL].The Lancet. Diabetes & Endocrinology, 2024,12(9): 674-680.
[7] CHEN C, SONG M. Visualizing a field of research: A methodology of systematic scientometric reviews[J/OL]. PloS One,2019,14(10):e0223994.
[8] Science Mapping: A Systematic Review of the Literatu re[EB/OL].[2025-01-02].https://sciendo.com/article/10.1515/jdis-2017-0006.
[9] ARIA M, CUCCURULLO C. bibliometrix: An R-tool for comprehensive science mapping analysis[J/OL]. Journal of Informetrics,2017,11(4):959-975[2025-01-02].https://www.sciencedirect.com/science/article/pii/S1751157717300500.
[10] KOSMAS C E, BOUSVAROU M D, KOSTARA C E, 等. Insulin resistance and cardiovascular disease[J/OL]. The Journal of International Medical Research,2023,51(3):3000605231164548.
[2] LOCATELLI J C, COSTA J G, HAYNES A, 等. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optim ize Changes in Body Composition?[J/OL].Diabetes Care,2024, 47(10):1718-1730.
[3] TAKANO C, OGAWA E, HAYAKAWA S. Insulin Resistance in Mitochondrial Diabetes[J/OL]. Biomolecules,2023,13(1):126.
[4] ZHAO Y, YUE R. Aging adipose tissue, insulin resistance, and type 2 diabetes[J/OL]. Biogerontology,2024,25(1):53-69.
[5] MAHAPATRA M K, KARUPPASAMY M, SAHOO B M. Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity,Non-Alcoholic Steatohepatitis and Neurodege nerative diseases: A Narrative Review[J/OL]. Pharmaceutical Research,2022,39(6):1233-1248.
[6] ABDUL-GHANI M,MAFFEI P,DEFRONZO R A.Managing insul in resistance: the forgotten pathophysiological component of type 2 diabetes[J/OL].The Lancet. Diabetes & Endocrinology, 2024,12(9): 674-680.
[7] CHEN C, SONG M. Visualizing a field of research: A methodology of systematic scientometric reviews[J/OL]. PloS One,2019,14(10):e0223994.
[8] Science Mapping: A Systematic Review of the Literatu re[EB/OL].[2025-01-02].https://sciendo.com/article/10.1515/jdis-2017-0006.
[9] ARIA M, CUCCURULLO C. bibliometrix: An R-tool for comprehensive science mapping analysis[J/OL]. Journal of Informetrics,2017,11(4):959-975[2025-01-02].https://www.sciencedirect.com/science/article/pii/S1751157717300500.
[10] KOSMAS C E, BOUSVAROU M D, KOSTARA C E, 等. Insulin resistance and cardiovascular disease[J/OL]. The Journal of International Medical Research,2023,51(3):3000605231164548.
Copyright © 2025 邹林, 韩桂艳
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
